🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Juiwanna Kushner

Wayne State University

ORCID: 0009-0006-9880-8703

Also affiliated with The Barbara Ann Karmanos Cancer Institute

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 9 papers. Top paper: “The HDAC and PI3K dual inhibitor CUDC-907 synergistically enhances the antileukemic activity of venetoclax in preclinical models of acute myeloid leukemia”.

The HDAC and PI3K dual inhibitor CUDC-907 synergistically enhances the antileukemic activity of venetoclax in preclinical models of acute myeloid leukemia

Haematologica(2020)10.3324/haematol.2019.233445
N/A
0.598DataRank · unranked
53 citations

Yongwei Su, Katie Hege, Gerard J. Madlambayan, Holly Edwards, Tristan Knight +13 more

Cotargeting of Mitochondrial Complex I and Bcl-2 Shows Antileukemic Activity against Acute Myeloid Leukemia Cells Reliant on Oxidative Phosphorylation

Cancers(2020)10.3390/cancers12092400
N/A
0.574DataRank · unranked
45 citations

Hasini A. Kalpage, Deying Wang, Holly Edwards, Maik Hüttemann, Jun Ma +11 more

Enhancing anti-AML activity of venetoclax by isoflavone ME-344 through suppression of OXPHOS and/or purine biosynthesis in vitro

Biochemical Pharmacology(2023)10.1016/j.bcp.2023.115981
N/A
0.442DataRank · unranked
18 citations

Yongwei Su, Shraddha Patel, Cassandra L. Ramage, Jianlei Zhao, Brianna R. Temby +24 more

Enhancing anti-AML activity of venetoclax by isoflavone ME-344 through suppression of OXPHOS and purine biosynthesis

Research Square(2023)10.21203/rs.3.rs-2843025/v1
N/A
0.165DataRank · unranked
2 citations

Katie Hege-Hurrish, Yongwei Su, Shraddha Patel, Cassandra L. Ramage, Jenna L. Carter +22 more

Inhibition of CDK9 by voruciclib synergistically enhances cell death induced by the Bcl-2 selective inhibitor venetoclax in preclinical models of acute myeloid leukemia

Signal Transduction and Targeted Therapy(2020)10.1038/s41392-020-0112-3
N/A
0DataRank · unranked
68 citations

Yongwei Su, Jun Ma, Xinyu Li, Steven Buck, Holly Edwards +8 more

Inhibition of CDK 9 enhances AML cell death induced by combined venetoclax and azacitidine

Molecular Oncology(2025)10.1002/1878-0261.70124
N/A
0DataRank · unranked
0 citations

Jianlei Zhao, Aaban Asfar Azmi, Avanti Gupte, Jenna Thibodeau, Shuang Liu +14 more

The combination of CUDC-907 and gilteritinib shows promising in vitro and in vivo antileukemic activity against FLT3-ITD AML

Blood Cancer Journal(2021)10.1038/s41408-021-00502-7
N/A
0DataRank · unranked
40 citations

Jun Ma, Tristan Knight, Yongwei Su, Holly Edwards, Lisa Polin +12 more

The Imipridone ONC213 Targets α-Ketoglutarate Dehydrogenase to Induce Mitochondrial Stress and Suppress Oxidative Phosphorylation in Acute Myeloid Leukemia

Cancer Research(2024)10.1158/0008-5472.can-23-2659
N/A
0DataRank · unranked
21 citations

Jenna L. Carter, Xinyu Li, Yu Fukuda, Ashley Gray, John P. Lynch +29 more

Targeting ribonucleotide reductase to enhance the antileukemic activity of gilteritinib against chemoresistant FLT3- internal tandem duplication acute myeloid leukemia

ASPET Discovery(2025)10.1016/j.aspetd.2025.100014
N/A
0DataRank · unranked
0 citations

Jianlei Zhao, Jenna Thibodeau, Holly Edwards, Jing Li, Xun Bao +12 more